CONDUENT Inc Q3 FY2025 earnings call

Management Statement and Operational Highlights

• Financial Performance: Q3 2025 adjusted revenue was $767 million, in line with guidance. Adjusted EBITDA was $40 million, with a margin of 5.2% (up from prior periods).
• Sales and Pipeline: Consistent sales performance with an expanding pipeline. Transportation business remains strong, and the Government pipeline shows strong buying signals. Commercial sales are behind due to go-to-market changes, but pent-up demand exists in the Commercial space.
• Portfolio Rationalization: Portfolio rationalization efforts continue, with plans to discuss further in Q4 earnings. The company refinanced its revolving credit facility to simplify the balance sheet.
• AI Initiatives: The company has embedded Gen AI in solutions, launched an AI experience center in New Jersey, and deployed real production AI solutions in areas like agent assist, language smoothing, and fraud reduction, driving margin expansion and new revenue opportunities.

Segment Performance

• Commercial Segment: Adjusted revenue was $367 million in Q3 2025, down 4.7% year-over-year. Excluding the largest client, top 25 Commercial accounts grew, especially in healthcare. Adjusted EBITDA was $37 million, with an adjusted EBITDA margin of 10.1% (up 100 basis points year-over-year).
• Government Segment: Adjusted revenue was $238 million, down 6.7% year-over-year due to implementation delays and a client canceling an implementation. Adjusted EBITDA was $61 million, with an adjusted EBITDA margin of 25.6% (up 210 basis points year-over-year) driven by AI initiatives and efficiency programs.
• Transportation Segment: Adjusted revenue was $162 million, up 14.9% year-over-year, driven by strong equipment sales in international transit. Adjusted EBITDA was $4 million, with an adjusted EBITDA margin of 2.5% (up 250 basis points year-over-year).

Guidance

• 2025 Outlook: Adjusted EBITDA margin is expected to be between 5% and 5.5%. Adjusted revenue for the year is now projected to be between $3.05 billion and $3.1 billion. Adjusted free cash flow is dependent on timing items related to contract amendments and milestone recognition.
• 2026 Expectations: Management plans to lay out 2026 expectations when delivering Q4 earnings in February 2026.

Risks

• Government Shutdown Impact: Uncertainty around the timing of milestone payments and deal approvals due to the federal government shutdown affects cash flow and revenue recognition.
• Commercial Sales Challenges: Volume declines in the largest Commercial client and the need to improve the go-to-market approach and business development leadership in Commercial sales.

Question and Answer

• Q: Near closes in Q2 expected to close in Q3, how much closed and impact of government shutdown easing? A: Closings were affected by the timing of federal government deal approvals, especially in areas like CMS. No massive change from Q3 to prior quarters, but improvement could occur once the shutdown eases.
• Q: Measuring productivity/quality gains from Gen AI deployment? A: Primary pilot in Government is in fraud reduction (Direct Express program). In Commercial, it's in customer experience. Fraud reduction is seen in Government, while margin expansion and new revenue opportunities are expected in Commercial.
• Q: Stranded costs and internal timeline for benefits? A: Initial phase of stranded costs from divestitures is complete. Phase 2 of portfolio rationalization is ongoing, with continual cost optimization efforts in spans and layers and real estate portfolio.
• Q: Changing contract clauses to reduce churn risk? A: No immediate changes to contract clauses are planned, as the revenue stream isn't affected by the shutdown, and the business is primarily state and local government-focused.
• Q: Client mix on AI endeavors and Commercial bandwidth? A: Commercial AI focus is in healthcare (30%-40%). In Government, it's in Medicaid processing. The company is focused on client penetration and has a new business development team to address Commercial pipeline expansion.